Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
Mild nausea or dizziness in rare cases
GLP-1Rs exhibit broad tissue distribution, spanning the pancreas, gastrointestinal tract, cardiovascular system, and central nervous system, allowing GLP-1 RAs to impact multiple organ systems 2,3
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, modulates hunger signals rather than eliminating them entirely
These medications are FDA-approved for chronic weight management in individuals with obesity or those who are overweight with weight-related health concerns
US$ 24.37
US$ 21.87
US$ 23.19
US$ 20.19
US$ 28.79
US$ 26.59
